TickerFacts.

A business in context

RCEL research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4/A · Ownership change

    Report date 2026-06-12 · 0001193125-26-363747

  2. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-344787 · Items 1.01,9.01

  3. 8-K/A · Current report

    Report date 2026-06-03 · 0001193125-26-338135 · Items 5.07

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338101

  5. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338011 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-06-12 · 0001193125-26-269544

  7. 4 · Ownership change

    Report date 2026-06-09 · 0001193125-26-266397

  8. 4 · Ownership change

    Report date 2026-06-09 · 0001193125-26-263968

  9. 8-K · Current report

    Report date 2026-06-05 · 0001762303-26-000011 · Items 1.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-03 · 0001709989-26-000011

  11. 4 · Ownership change

    Report date 2026-06-03 · 0001816242-26-000002

  12. 8-K · Current report

    Report date 2026-06-03 · 0001762303-26-000003 · Items 5.02,5.07

  13. 4 · Ownership change

    Report date 2026-06-03 · 0001709989-26-000008

  14. 4 · Ownership change

    Report date 2026-06-03 · 0001603289-26-000002

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-224107

  16. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-224022 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2026-04-30 · 0001193125-26-201662 · Items 5.02,7.01,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-04-22 · 0001193125-26-170562

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-049031

  20. 8-K · Current report

    Report date 2026-02-12 · 0001193125-26-048761 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-011167 · Items 1.01,1.02,2.02,2.03,3.02,9.01

  22. 8-K · Current report

    Report date 2026-01-01 · 0001193125-26-002418 · Items 5.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269597

  24. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-269535 · Items 1.01,2.02,9.01

  25. 8-K · Current report

    Report date 2025-10-16 · 0001193125-25-241705 · Items 5.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-08-12 · 0001762303-25-000026 · Items 3.02

  27. 8-K · Current report

    Report date 2025-08-12 · 0001762303-25-000023 · Items 8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001762303-25-000014

  29. 8-K · Current report

    Report date 2025-08-07 · 0001762303-25-000012 · Items 1.01,2.02,9.01

  30. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-104019 · Items 5.02,9.01

  31. 8-K · Current report

    Report date 2025-06-04 · 0000950170-25-081880 · Items 5.02,5.07

  32. 8-K · Current report

    Report date 2025-05-15 · 0000950170-25-072746 · Items 5.03,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066994

  34. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066911 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-04-22 · 0000950170-25-056785

  36. 8-K · Current report

    Report date 2025-03-17 · 0000950170-25-040249 · Items 1.01,7.01,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-020026

  38. 8-K · Current report

    Report date 2025-02-13 · 0000950170-25-019862 · Items 1.01,2.02,9.01

  39. 8-K · Current report

    Report date 2025-01-07 · 0000950170-25-002907 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-123326

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 11 transaction rows11PSale: 0 transaction rows0SGrant / award: 19 transaction rows19AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

30 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-12
2026-06-12
O'Toole David DA · Grant / award
Acquired
Common Stock2000.03.97
2026-06-09
2026-06-10
Woody Joseph FralinP · Purchase
Acquired
Common Stock5200.04.0
2026-06-09
2026-06-09
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.18
2026-06-09
2026-06-09
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.2
2026-06-03
2026-06-05
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.09
2026-06-03
2026-06-05
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.1
2026-06-02
2026-06-03
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.21
2026-06-02
2026-06-03
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.18
2026-06-01
2026-06-03
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.26
2026-06-01
2026-06-03
Woody Joseph FralinP · Purchase
Acquired
Common Stock5000.04.34
2026-05-29
2026-06-01
O'Toole David DA · Grant / award
Acquired
Common Stock5000.03.05
2026-05-29
2026-06-01
Vance Cary GuyA · Grant / award
Acquired
Common Stock5000.03.05
2026-05-20
2026-05-20
O'Toole David DP · Purchase
Acquired
Common Stock2000.04.26
2026-05-19
2026-05-19
O'Toole David DP · Purchase
Acquired
Common Stock2000.04.24
2026-01-20
2026-06-04
Crowe SuzanneA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
Crowe SuzanneA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-20
2026-06-04
Woody Joseph FralinA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
Woody Joseph FralinA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-20
2026-06-04
Tarnoff Michael EA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
Tarnoff Michael EA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-20
2026-06-04
McNamara RobertA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
McNamara RobertA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-20
2026-06-04
COOK JEREMY CURNOCKA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
COOK JEREMY CURNOCKA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-20
2026-06-04
REED JAN STERNA · Grant / award
Acquired
Common Stock22214.0—
2026-01-20
2026-06-04
REED JAN STERNA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
16133.00.0
2026-01-05
2026-06-04
Woody Joseph FralinA · Grant / award
Acquired
Common Stock40547.0—
2026-01-05
2026-06-04
Woody Joseph FralinA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
29446.00.0
2025-08-06
2026-06-04
Tarnoff Michael EA · Grant / award
Acquired
Common Stock26250.0—
2025-08-06
2026-06-04
Tarnoff Michael EA · Grant / award
Acquired
Stock Options (Right to Buy)
Derivative security
19063.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001762303AVITA Medical, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Avita Medical · alias · wikidata
  • Avita Therapeutics, Inc. · former SEC name · 2020-07-06 to 2020-12-10
  • Avita Medical, Ltd. · former SEC name · 2018-12-19 to 2020-06-30
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$64.25M$68.39M
2023-12-31$50.14M$54.95M
2022-12-31$34.42M$39.27M
2021-06-30$29.23M$37.10M
2020-06-30$14.26M$18.52M
2019-06-30$5.47M$7.22M
2018-06-30$929.0K$1.25M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗